In addition to affecting pancreatic cancer cells biology in an intrinsic manner, KRAS mutation can also indirectly affect pancreatic cancer cells by regulating the tumor microenvironment (TME). This evidence concerns the gene KRAS and familial pancreatic carcinoma.